ThomasP

About Thomas Mathew

This author has not yet filled in any details.
So far Thomas Mathew has created 9 blog entries.

Why Visibility Matters: How a Biotechnology Directory Drives B2B Leads

The biotechnology industry is built on innovation, collaboration and specialised expertise.  Yet even the most innovative companies can struggle to grow if potential customers, partners, investors and suppliers simply don't know they exist.  Whether a company develops pharmaceuticals, biologics, vaccines, medical devices, diagnostics, agricultural biotechnology solutions, contract manufacturing services, regulatory consulting, laboratory equipment, or clinical research services, visibility [...]

2026-09-06T00:12:33+08:00Company Focus, Company News, The Biotechnology Industry, The Biotech Directory|
Read More

Which Countries Are Winning the Global Biotechnology Talent War?

The biotechnology industry has always been driven by innovation, but innovation itself depends on one critical resource:  people.  Whether developing life-saving pharmaceuticals, next-generation medical devices, advanced diagnostics, breakthrough vaccines, biologics, cell therapies, agricultural biotechnology solutions, or synthetic biology platforms, success ultimately depends on attracting and retaining highly skilled talent.  As biotechnology continues to expand [...]

2026-09-05T23:46:33+08:00Current Trends|
Read More

The UK: From Oxford to DeepMind ‑ Inside the UK’s Computational Biology Boom

For decades, the United Kingdom has been recognised as one of the world's leading centres for life sciences research.  Home to world-class universities, globally influential pharmaceutical companies, pioneering biotechnology start-ups and one of the world's most respected healthcare systems, the UK has consistently punched above its weight in scientific innovation.  Today, however, [...]

2026-09-05T16:21:53+08:00Industry News|
Read More

The Great Biotech IPO Drought: What’s Keeping Companies Private Longer?

There was a time when a promising young biotech company with a brilliant laboratory breakthrough and strong preclinical data could confidently look toward Wall Street.  An Initial Public Offering (IPO) was the standard rite of passage ‑ a way to secure the massive injection of capital required to push a molecule through the gruelling, multi-year [...]

2026-09-05T15:41:17+08:00Industry News|
Read More

The Future of Agricultural Biotechnology and Food Security

As the world's population continues to grow and climate change places increasing pressure on agricultural systems, ensuring global food security has become one of the defining challenges of the 21st century.  According to projections from international organisations, the global population could approach 10 billion people by 2050, requiring substantial increases [...]

2026-09-04T19:08:20+08:00The Biotechnology Industry|
Read More

Organ-on-a-Chip: How Microfluidics is Replacing Animal Models

For decades, animal models have been a cornerstone of biomedical research.  From testing new medicines to studying disease mechanisms, laboratory animals have played an essential role in advancing healthcare.  Yet researchers have long recognised their limitations.  Biological differences between animals and humans can make it difficult to predict how a drug will [...]

2026-09-04T18:05:14+08:00Industry News|
Read More

Data Privacy in Genomics: Who Really Owns Your DNA?

With a simple swipe of a cotton swab or a small tube of saliva, you can now unlock the deepest secrets of your biology.  Direct-to-consumer (DTC) genetic testing has skyrocketed in popularity, promising to reveal everything from your ancestral roots to your predisposition for certain medical conditions.  But once [...]

2026-09-03T18:14:36+08:00General Interest|
Read More

BioNTech’s Bet on Cancer: Inside the mRNA Oncology Pipeline

For many people, BioNTech became a household name during the COVID-19 pandemic.  Its partnership with Pfizer delivered one of the first successful mRNA vaccines against SARS-CoV-2, demonstrating not only the speed of modern biotechnology but also the immense potential of messenger RNA (mRNA) as a therapeutic platform.  Yet long [...]

2026-09-02T15:06:00+08:00Industry News|
Read More
Copyright (C) 2026 The Biotech Directory | All Rights Reserved |
Go to Top